Ibuprofen Sodium

CHEMBL3989408 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
264.3 g/mol
LogP
Phase
4

A sodium salt form of ibuprofen with the same therapeutic properties. This widely used nonsteroidal anti-inflammatory drug (NSAID) relieves pain, reduces fever, and decreases inflammation by blocking cyclooxygenase (COX) enzymes that produce prostaglandins.

분자량

264.2900 g/mol

TPSA

42.10 Ų

치료 영역

작용 기전

Inhibits cyclooxygenase (COX-1 and/or COX-2) enzymes, reducing the synthesis of prostaglandins and thromboxanes from arachidonic acid. This produces anti-inflammatory, analgesic, and antipyretic effects.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

기전

Inhibits cyclooxygenase (COX-1 and/or COX-2) enzymes, reducing the synthesis of prostaglandins and thromboxanes from arachidonic acid. This produces anti-inflammatory, analgesic, and antipyretic effects.

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.O.O.[Na+]

InChI

InChI=1S/C13H18O2.Na.2H2O/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15;;;/h4-7,9-10H,8H2,1-3H3,(H,14,15);;2*1H2/q;+1;;/p-1

Molecular Formula

C13H21NaO4

HBD / HBA

2 / 4

회전 가능 결합

4

무거운 원자

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

A sodium salt form of ibuprofen with the same therapeutic properties. This widely used nonsteroidal anti-inflammatory drug (NSAID) relieves pain, reduces fever, and decreases inflammation by blocking cyclooxygenase (COX) enzymes that produce prostaglandins.

Inhibits cyclooxygenase (COX-1 and/or COX-2) enzymes, reducing the synthesis of prostaglandins and thromboxanes from arachidonic acid. This produces anti-inflammatory, analgesic, and antipyretic effects.

Yes, Ibuprofen Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989408. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23690315. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.